These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32236960)

  • 21. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
    Zhou Y; Pirmann S; Lauschke VM
    Pharmacogenomics J; 2024 May; 24(3):17. PubMed ID: 38802404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.
    Marrero RJ; Cicali EJ; Arwood MJ; Eddy E; DeRemer D; Ramnaraign BH; Daily KC; Jones D; Cook KJ; Cavallari LH; Wiisanen Weitzel K; Langaee T; Newsom KJ; Starostik P; Clare-Salzer MJ; Johnson JA; George TJ; Cooper-DeHoff RM
    Clin Pharmacol Ther; 2020 Sep; 108(3):557-565. PubMed ID: 32460360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project".
    O'Donnell PH; Danahey K; Jacobs M; Wadhwa NR; Yuen S; Bush A; Sacro Y; Sorrentino MJ; Siegler M; Harper W; Warrick A; Das S; Saner D; Corless CL; Ratain MJ
    Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):68-75. PubMed ID: 24616296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of pharmacogenomics into inpatient general medicine.
    Chen T; O'Donnell PH; Middlestadt M; Ruhnke GW; Danahey K; van Wijk XMR; Choksi A; Knoebel R; Hartman S; Yeo KJ; Friedman PN; Ratain MJ; Nutescu EA; O'Leary KJ; Perera MA; Meltzer DO
    Pharmacogenet Genomics; 2023 Feb; 33(2):19-23. PubMed ID: 36729768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation.
    Winner JG; Carhart JM; Altar CA; Goldfarb S; Allen JD; Lavezzari G; Parsons KK; Marshak AG; Garavaglia S; Dechairo BM
    Curr Med Res Opin; 2015; 31(9):1633-43. PubMed ID: 26086890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
    McKillip RP; Borden BA; Galecki P; Ham SA; Patrick-Miller L; Hall JP; Hussain S; Danahey K; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Ratain MJ; Meltzer DO; O'Donnell PH
    Clin Pharmacol Ther; 2017 Jul; 102(1):106-114. PubMed ID: 27981566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention.
    Mahdieh N; Rabbani A; Firouzi A; Zahedmehr A; Hoseinimoghaddam M; Saedi S; Sanati H; Basiri H; Noohi F; Rabbani B; Maleki M
    Cardiovasc Toxicol; 2018 Oct; 18(5):482-491. PubMed ID: 29777510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient insights on features of an effective pharmacogenomics patient portal.
    Truong TM; Lipschultz E; Schierer E; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2020 Dec; 30(9):191-200. PubMed ID: 33017129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients.
    Lewis JP; Backman JD; Reny JL; Bergmeijer TO; Mitchell BD; Ritchie MD; Déry JP; Pakyz RE; Gong L; Ryan K; Kim EY; Aradi D; Fernandez-Cadenas I; Lee MTM; Whaley RM; Montaner J; Gensini GF; Cleator JH; Chang K; Holmvang L; Hochholzer W; Roden DM; Winter S; Altman RB; Alexopoulos D; Kim HS; Gawaz M; Bliden KP; Valgimigli M; Marcucci R; Campo G; Schaeffeler E; Dridi NP; Wen MS; Shin JG; Fontana P; Giusti B; Geisler T; Kubo M; Trenk D; Siller-Matula JM; Ten Berg JM; Gurbel PA; Schwab M; Klein TE; Shuldiner AR;
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):203-210. PubMed ID: 31504375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.
    Lee YM; McKillip RP; Borden BA; Klammer CE; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2017 May; 27(5):179-189. PubMed ID: 28267054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacogenetics: how do we ensure a favorable future for patients?
    Wiltshire T; Dong OM
    Pharmacogenomics; 2018 Apr; 19(6):553-562. PubMed ID: 29620450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
    Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
    Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
    Van Driest SL; Shi Y; Bowton EA; Schildcrout JS; Peterson JF; Pulley J; Denny JC; Roden DM
    Clin Pharmacol Ther; 2014 Apr; 95(4):423-31. PubMed ID: 24253661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
    Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
    J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies.
    Samwald M; Miñarro Giménez JA; Boyce RD; Freimuth RR; Adlassnig KP; Dumontier M
    BMC Med Inform Decis Mak; 2015 Feb; 15():12. PubMed ID: 25880555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
    Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
    Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.